User Name: Password:      Register - Lost password?

2003  2004  2005  2006  2007  2008  2009  2010  2011  2012  2013  2014  2015  2016  2017  2018  2019  2020  2021  2022  2023  
January  February  March  April  May  June  July  August  September  October  November  December  
01 02 03 04 05 06 07 08 09 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30

Forex Forum Archive for 11/26/2020

Pick a date from the header above to view forum postings for that day.
Click here to join the Live Forex Forum.

dc CB 22:13 GMT November 26, 2020
Meet Pres Elect Biden's Secy of State
'a vomit milkshake', Matt Taibbi writing about the 2020 election.

My view - we are now playing 'Fantasy Football'.

The website for WestExec Advisors includes a map depicting West Executive Avenue, the secure road on the White House grounds between the West Wing and the Eisenhower Executive Office Building, as a way to show what the consulting firm can do for its clients.

“It is, quite literally, the road to the Situation Room, and it is the road everyone associated with WestExec Advisors has crossed many times en route to meetings of the highest national security consequences,” the firm says.

And staffers are poised to cross it again — en masse.

POLITICO. Transition 2020

The secretive consulting firm that’s become Biden’s Cabinet in waiting

Mtl JP 19:01 GMT November 26, 2020
this is good one...

Oh Oh ooooohh
Bitcoin 16609.14 -9.37%
who does not like volatility ?
Bitcoin correction
Bitcoin prices fell more than 15% in about 24 hours

Bitcoin price plunges over 10% to stage Thanksgiving correction

AT Trader john 18:00 GMT November 26, 2020
Friday Amazing Trader 27 November 2020

GVI Trading. Potential Price Risk Scale
AA: Major, A: High, B: Medium

Fri 27 Nov 2020
A 00:00 US- Holiday(partial)

GVI Trading. Potential Price Risk Scale
AA: Major, A: High, B: Medium

Mon 30 Nov 2020
B 15:00 US- Pending Homes
A 14:45 US- Chicago PMI
Tue 1 Dec 2020
Final Mfg PMIs
A 08:00 DE- Retail Sales/Jobs
AA 09:00 EZ- flash HICP
Wed 2 Dec 2020
AA 09:00 EZ- flash HICP
A 13:15 US- ADP Payrolls
A 15:30 US- EIA Crude

Mtl JP 17:44 GMT November 26, 2020
Thursday Amazing Trader 26 November 2020

GBP 1.3359
barnier de-confines on friday. this EU prince had the cheek to tell frost that he will sulk and not travel to london unless UK makes concessions

I suppose GBP should pop some if word gets out barnier bought travel ticket BUT I am still betting the brits will be happy to get shot of barnier (ie no brexit deal)

Botton Line
Lurking for a waterfall GBP price move.

Mtl JP 17:07 GMT November 26, 2020

PAR 15:06 - that is 1/2 of how one cultivates mushrooms: in the dark

AT Trader john 16:56 GMT November 26, 2020
Friday Amazing Trader 27 November 2020

LATE Thursday: Mixed RISK
DJ: 29,872 -174
SP: 3,630 -6
NQ: 12,094 +58

2-yr 0.162% -0.2 bp
Spread 10s-2s +72.0bp (+70.9)

US: 0.882% 0.0 bp UK: 0.289% -0.3 bp
DE: -0.584% -1.3

Spots (Pivot Point prev day)
EURUSD 1.1897 (1.1908)
GBPUSD 1.3332 (1.3351)
EURGBP 0.8924 (0.8920)
USDJPY 104.30 (104.34)

Thls Week 1.1941-1.1801 (140 pips)
thu: 1.1941-1.1886 (55)
wed: 1.1930-1.1882 (48)
tue: 1.1895-1.1834 (45)
mon: 1.1906-1.1801 (95)
fri: 1.1891-1.1850 (41)
20-d avg: 1.1809
50-day avg: 1.1775
100-day avg: 1.1764
200-day avg: 1.1411

Global-View Daily Trading Chart Points

dc CB 16:47 GMT November 26, 2020

But we're working really really really really hard to Change that...because it was set up by a bunch of OWMs- Old White Men

'remember, you wanted this' Jack Reacher
Michael David Smith
The mayor of Denver is traveling to Mississippi to visit his daughter after urging everyone not to travel for Thanksgiving. This thread boils down to, "I said we all need to sacrifice, but by 'we' I meant 'you'."
Michael B. Hancock
I fully acknowledge that I have urged everyone to stay home and avoid unnecessary travel. I have shared how my family cancelled our plans for our traditional multi-household Thanksgiving celebration. (1/5)
7:13 PM · Nov 25, 2020

PAR 16:40 GMT November 26, 2020
Meanwhile, Italy has a novel idea to help nations recover and restructure their economies: get the ECB to cancel the debt it buys. "Monetary policy must support member states' expansionary fiscal policies in every possible way," Giuseppe Conte's closest aide said. That could include "canceling sovereign bonds bought during the pandemic or perpetually extending their maturity."

Giuseppe Conte's love affair with Christine Lagarde?

dc CB 16:36 GMT November 26, 2020

dc CB 22:12 GMT 11/25/2020
America: 3 branches of government. Legislative, Executive, Judicias. American form of gov Checks and Balances --- 18th century cutting edge thought.


The Supreme Court late Wednesday blocked New York officials from limiting religious gatherings, a win for Orthodox Jews who had sued over restrictions imposed during the COVID-19 pandemic.

"Members of this Court are not public health experts, and we should respect the judgment of those with special expertise and responsibility in this area," the majority opinion said.

"But even in a pandemic, the Constitution cannot be put away and forgotten. The restrictions at issue here, by effectively barring many from attending religious services, strike at the very heart of the First Amendment’s guarantee of religious liberty."

In a 5-4 decision, the nation’s highest court said New York Gov. Andrew Cuomo, a Democrat, and other officials cannot enforce occupancy limits set in a previous executive order.

Cuomo had mandated that attendance at religious services remain at 10 people or under in so-called red zones and at 25 or under in orange zones.

New York officials have created a color-coding system to mark what levels they believe the pandemic has affected certain areas.

Lawsuits brought by he Roman Catholic Diocese of Brooklyn and Agudath Israel of America triggered the ruling.

PAR 16:09 GMT November 26, 2020


Entry: PAR Target: Stop:

Political prisoners in Spain.

Gestapo practices in Belgium.

And Europe is worried about Poland and Hungary?

Police State

GVI Forex Blog 15:37 GMT November 26, 2020
Chart Points: Free Forex Database For 26 November 2020

forex rate database image

Global-View Free FX Database. High-Low-Close data for more than a dozen currency pairs for over seventeen years of data in an Excel spreadsheet format.

Global-View Daily Trading Chart Points

Chart Points: Free Forex Database For 26 November 2020

Hk Ab 15:37 GMT November 26, 2020
Close half 1810

Hk Ab 15:10 GMT November 26, 2020
Lol, plenty of adding opportunities

PAR 15:06 GMT November 26, 2020
ECB minutes: It was cautioned that the governing council should not pre-commit to specific policy actions

Hk Ab 14:55 GMT November 26, 2020
Gold hard to break bottom when gvi quacks sell...

Hk Ab 14:51 GMT November 26, 2020
Put a 100 lots buy limit 1801.5 and SAR S/l 1799

Hk Ab 14:43 GMT November 26, 2020

Try bought 1808.5

PAR 14:02 GMT November 26, 2020
AstraZeneca Faces More Vaccine Questions After Manufacturing Error

Tout va très bien, Madame la Marquise

Everything is fine

Tallinn viies 13:54 GMT November 26, 2020
previous day held again. now back to 1,1950? any ideas

Jkt Abel 13:24 GMT November 26, 2020
Cable support

haifa ac 11:05 GMT November 26, 2020

"P/E ratio of 1100"

In the dotcom bubble of 2000 there were about 2500 companies who traded at P/E ratio of IFINITY (zero earnings) until it all burst.

Mtl JP 10:57 GMT November 26, 2020
Thursday Amazing Trader 26 November 2020

big news:
European stocks struggle for traction as virus worries, U.S. Thanksgiving holiday keep investors on the sidelines
- MarketWatch

Mtl JP 10:43 GMT November 26, 2020
this is good one...

this is good one ...
excess cash: oh the fun fun FUN that is coming
btc.: $17213
..."MicroStrategy announced adopting bitcoin as its primary treasury reserve asset and planned to pick up more in the future with any excess cash."...

MicroStrategy shares jump 5.5% after Citron says there's 'no better way to play bitcoin'

Amman wfakhoury 10:35 GMT November 26, 2020
EURUSD 11910

Syd Jk 10:05 GMT 11/26/2020
Ha ha ha can join my PAMM account.

Mtl JP 10:26 GMT November 26, 2020

red 20:30 Gnext year is the year of inflation.
how do u insert Gold into that pic ? tia

Israel MacroMicro 10:13 GMT November 26, 2020

I can see some profit taking to take place above $600

PAR 10:11 GMT November 26, 2020
TESLA @ $ 575 P/E ratio of 1100. Guess they need more subsidies?

Israel MacroMicro 10:11 GMT November 26, 2020
DRS2 and BTC

BKB - babi kecap boy

only JP is allowed to use MaMi - lol

seriously, I am not doing crypto, I prefer lumber and jet fuel as volatility instruments.

Syd Jk 10:05 GMT November 26, 2020
EURUSD 11910

Mr What the Fak Hourly is back after blowing up his Demo account.

jkt abel 09:57 GMT November 26, 2020
DRS2 and BTC

MaMi, just buy all btc dips 15-16k, they said btc to be 100k in 2021 right?

AT Trader john 09:57 GMT November 26, 2020
Thursday Amazing Trader 26 November 2020

Thanks. I was just going with Wed NY closes as all U.S. markets on holiday today.

Israel MacroMicro 09:53 GMT November 26, 2020
Thursday Amazing Trader 26 November 2020

John, NQ is more like 12194
have a great Thanksgiving

Amman wfakhoury 09:46 GMT November 26, 2020
EURUSD 11910

11910 welcome now

AT Trader john 09:44 GMT November 26, 2020
Thursday Amazing Trader 26 November 2020

Thursday: Mixed RISK
DJ: 29,872 -174
SP: 3,630 -6
NQ: 12,094 +58

2-yr 0.162% -0.2 bp
Spread 10s-2s +72.0bp (+70.9)

US: 0.882% 0.0 bp UK: 0.311% -0.8 bp
DE: -0.539% +0.2 bp

Spots (Pivot Point prev day)
EURUSD 1.1917 (1.1909)
GBPUSD 1.3370 (1.3361)
EURGBP 0.8914 (0.8910)
USDJPY 104.25 (104.40)

This Week 1.1941-1.1801 (140 pips)
thu: 1.1941-1.1911 (30)
wed: 1.1930-1.1882 (48)
tue: 1.1895-1.1834 (45)
mon: 1.1906-1.1801 (95)
fri: 1.1891-1.1850 (41)
20-d avg: 1.1795
50-day avg: 1.1773
100-day avg: 1.1759
200-day avg: 1.1406

Global-View Daily Trading Chart Points

Amman wfakhoury 09:37 GMT November 26, 2020
EURUSD 11910
11910 is coming

jkt abel 09:35 GMT November 26, 2020
eurgbp sell
looks like well capped at around 8920, sterling bulls in control

jkt abel 09:29 GMT November 26, 2020

red, you are saying that in UK they are using the elderly people as large scale proper clinical study next? since even health workers dare not taking it first? how unfilial society it is hahaha

PAR 09:20 GMT November 26, 2020
ECB’s Holzmann: Lower Deposit Rates Wouldn't Have Effect

Stopping with negative rates could have a positive impact on European
depressed banks, savers, and pensioners.

Israel MacroMicro 09:14 GMT November 26, 2020
DRS2 and BTC
he had the vision
now he got also the money

nice professional call with clear explanation, well done DRS2

PAR 09:11 GMT November 26, 2020
Even if the #ECB were to cancel all the debt it holds from Italy, that would be only a drop in the ocean. #Italy's debt has risen to almost €2.6tn, of which the ECB holds around €500bn.

HK Kevin 09:06 GMT November 26, 2020
Short term is bearish after break 1850

Would Bitcoin crazy fuel give impetus to Gold downside move?

london red 08:23 GMT November 26, 2020

in the uk vaccines are to be implemented in care homes early december, before even care workers get the jab. however as has been mentioned below, there isnt a queue of medical professionals jumping at the chance to take the jab, not before it can be tested over a longer period of time.
and brexit, i see ft100 down but they are buying international earning uk stocks that go up when sterling falls, also financials down a second day

Central Kwun 08:09 GMT November 26, 2020
Short term is bearish after break 1850
Sell Gold
Entry: 1816 Target: Stop: 1826

sell first, and buy back later

Hk Ab 05:33 GMT November 26, 2020
100 lots now avg 1815

dc CB 03:26 GMT November 26, 2020

add this piece to that one.

(last paragraph)
'These announcements by Pfizer and Moderna are encouraging. I certainly hope that these vaccines protect people from the harm of covid-19. I certainly hope that these vaccines are safe. If both of these conditions are true, nobody will need to be coerced into taking the vaccine. However, you should pay even more attention about what is left out of an announcement than about what is stated. The pharmaceutical companies are more than happy for patients to misunderstand what is meant by efficacy.

Pfizer recently announced that its covid vaccine was more than 90 percent “effective” at preventing covid-19. Shortly after this announcement, Moderna announced that its covid vaccine was 94.5 percent “effective” at preventing covid-19. Unlike the flu vaccine, which is one shot, both covid vaccines require two shots given three to four weeks apart. Hidden toward the end of both announcements, were the definitions of “effective.”

Both trials have a treatment group that received the vaccine and a control group that did not. All the trial subjects were covid negative prior to the start of the trial. The analysis for both trials was performed when a target number of “cases” were reached. “Cases” were defined by positive polymerase chain reaction (PCR) testing. There was no information about the cycle number for the PCR tests. There was no information about whether the “cases” had symptoms or not. There was no information about hospitalizations or deaths.

The Pfizer study had 43,538 participants and was analyzed after 164 cases. So, roughly 150 out 21,750 participants (less than 0.7 percent) became PCR positive in the control group and about one-tenth that number in the vaccine group became PCR positive.

The Moderna trial had 30,000 participants. There were 95 “cases” in the 15,000 control participants (about 0.6 percent) and 5 “cases” in the 15,000 vaccine participants (about one-twentieth of 0.6 percent). The “efficacy” figures quoted in these announcements are odds ratios.

There is no evidence, yet, that the vaccine prevented any hospitalizations or any deaths. The Moderna announcement claimed that eleven cases in the control group were “severe” disease, but “severe” was not defined. If there were any hospitalizations or deaths in either group, the public has not been told. When the risks of an event are small, odds ratios can be misleading about absolute risk. A more meaningful measure of efficacy would be the number to vaccinate to prevent one hospitalization or one death. Those numbers are not available.

An estimate of the number to treat from the Moderna trial to prevent a single “case” would be fifteen thousand vaccinations to prevent ninety “cases” or 167 vaccinations per “case” prevented which does not sound nearly as good as 94.5 percent effective. The publicists working for pharmaceutical companies are very smart people. If there were a reduction in mortality from these vaccines, that information would be in the first paragraph of the announcement.

There is no information about how long any protective benefit from the vaccine would persist. Antibody response following covid-19 appears to be short lived. Based on what we know, the covid vaccine may require two shots every three to six months to be protective. The more shots required, the greater the risk of side effects from sensitization to the vaccine.

There is no information about safety. None. Government agencies like the Centers for Disease Control (CDC) appear to have two completely different standards for attributing deaths to covid-19 and attributing side effects to covid vaccines. If these vaccines are approved, as they likely will be, the first group to be vaccinated will be the beta testers.

I am employed by a university-based medical center that is a referral center for the West Texas region. My colleagues include resident physicians and faculty physicians who work with covid patients on a daily basis. I have asked a number of my colleagues whether they will be first in line for the new vaccine. I have yet to hear any of my colleagues respond affirmatively. The reasons for hesitancy are that the uncertainties about safety exceed what they perceive to be a small benefit. In other words, my colleagues would prefer to take their chances with covid rather than beta test the vaccine. Many of my colleagues want to see the safety data after a year of use before getting vaccinated; these colleagues are concerned about possible autoimmune side effects that may not appear for months after vaccination.

What the Covid Vaccine Hype Fails to Mention
11/24/2020Gilbert Berdine, MD

Tallinn viies 02:19 GMT November 26, 2020

After year-long sprint, Covid-19 vaccines finally at hand

Less than a year after an unknown coronavirus that has claimed 1.4 million lives began spreading across the globe, a number of highly promising Covid-19 vaccines are on the cusp of release.

Health authorities could give a green light for emergency use within weeks, which would mark the most rapid vaccine development for a pandemic in history -- but many questions remain.
- When will a jab be available? -

After months without a visible breakthrough, everything sped up in November, when several pharmaceutical companies made encouraging preliminary announcements about the efficacy of their vaccines.

The European Medicines Agency (EMA), charged with overseeing drug approval in the European Union, told AFP that it could approve the first Covid-19 vaccines by the end of the year, or early in 2021. France, Spain and Italy have all sketched out distribution plans on that basis.

Across the Atlantic, vaccination campaigns could start in the United States as early as mid-December, assuming the US Food and Drug Administration (FDA) approves an accelerated timetable for rollout.

Chinese authorities have already begun jabbing high-risk patients, and in Russia two vaccines were validated for use even before the final phase of clinical trials had begun.

Researching, testing, approving, manufacturing and distributing a new vaccine usually takes a decade or longer.

The breakneck pace of development, resulting in half-a-dozen Covid-19 vaccines, saw an unprecedented blitzkrieg of public and private research backed by a huge sums of money and provisional orders for billions of doses.

But all parties involved insist that corners have not been cut.

The EU's regulatory agency, for example, acknowledged an effort "to speed up" the evaluation process, but insisted it was "ensuring the same high regulatory standards for quality, safety and efficacy" as for any other drug.

But this extraordinary achievement will not mean that a waiting world will be vaccinated right away.

"Initial supply of #COVID19 vaccines will be limited, so #healthworkers, older people and other at-risk populations will be prioritised," World Health Organization (WHO) head Tedros Adhanom Ghebreyesus recently tweeted.

The world's poorest countries, he warned, should not have to wait until wealthy ones that have reserved billions of doses are served.

"The urgency with which vaccines have been developed must be matched by the same urgency to distribute them fairly," he said, highlighting the risk that the poor and vulnerable will be "trampled in the stampede" to get inoculated.
- Which vaccine is best? -

Too early to say. Since November 9, four drug makers have announced that their vaccines work, most of them more than 90 percent of the time.

The first to report Phase 3 results was the US-German collaboration between pharmaceutical giant Pfizer and German biotech start-up BioNTech, followed by the US firm Moderna, a British partnership between AstraZeneca and Oxford University, and Russia's state-run Gamaleya Research Institute of Epidemiology and Microbiology.

But the rush for results in anticipation of a huge global market means the announcements were made by the companies themselves, and have yet to be backed up by publication in peer-reviewed journals, which can take months.

All the vaccines unveiled are near the end of so-called Phase 3 clinical trials, the final step in a process that tests safety and efficacy on tens of thousands of volunteers of different ages and ethnicities spread across the world.

Basically, the efficacy of a vaccine is determined by comparing the number of people who get sick with Covid-19 in a group of vaccinated volunteers compared to another group that receives a placebo instead of the active drug.

The threshold for releasing the findings -- the number of people infected with Covid-19 -- was different in each case: 170 for Pfizer/BioNTech, 95 for Moderna, 131 for AstraZeneca/Oxford, and only 39 for the Gamaleya Institute.

Pfizer reported 95 percent efficacy, with only eight of the 170 Covid-19 patients coming from the vaccinated group. For Moderna -- with 94.5 percent efficacy -- it was almost identical, while Gamaleya's Sputnik V vaccine reported 91.4 percent efficacy.

The calculations for AstraZeneca's two-dose vaccine were more complicated. Across two separate trials with slightly different protocols, the drug worked 70 percent of the time.

But in a group whose first jab was a half-dose rather than a full one, the efficacy rate rose to 90 percent, putting it in the same league as the others. The counter-intuitive result -- less vaccine conferring more protection -- stemmed from the reaction of the immune system, the company said.

But the success rate is not the only criterion in determining which vaccine will be adopted in different circumstances. Cost and logistics are also factors.

AstraZeneca's double jab, for example, is by far the least expensive, at about 2.5 euros ($3) per dose.

It also has a significant advantage when it comes to transport and storage. Moderna's vaccine must be kept at -20 degrees Celsius, while Pfizer's requires an even chillier -70C to remain viable. AstraZeneca's vaccine, by contrast, can be stored at the temperature of a normal fridge.
- What questions remain? -

There are plenty, including some big ones.

"We knew that a vaccine would be essential for bringing the pandemic under control," Adhanom Ghebreyesus noted. "But it's important to emphasise that a vaccine will complement the other tools we have, not replace them."

That said, the WHO chief, added, "the light at the end of this long, dark tunnel is growing brighter."

The biggest question mark hanging over all of these vaccines is how long immunity lasts. All the results were reported only a few weeks after the vaccines were administered.

"How long will protection last? Will vaccination result in virus 'escape' mutations which limit vaccine effectiveness over time?", Penny Ward, a visiting professor in pharmaceutical medicine at King's College London, told journalists, listing things we still need to know.

A handful of reinfections, in which people recovered from Covid-19 only to become infected by a slightly different strain, also raise questions about the duration of immunity.

Scientists also still don't know if the vaccines will be as effective with high-risk individuals, especially the elderly, who are far more susceptible to life-threatening symptoms.

Yet another "known unknown" is whether an effective vaccine simply eliminates the symptoms, or whether it also prevents someone from transmitting the virus to others.

In other words, even if it protects you from getting sick, will it protect others you come into contact with from catching the bug?

Here again, AstraZeneca may have an edge on the competition.

"The Oxford/AstraZeneca team has been collecting weekly nasal and throat swabs from all trial participants to look for asymptomatic infections," Eleanor Riley, a professor of immunology and infectious disease at the University of Edinburgh, told the Science Media Centre in London.

The drug maker found "early indication" that the vaccine could reduce virus transmission.

Contacted by AFP, AstraZeneca noted that not all 23,000 people in their trial were tested for asymptomatic cases, but did not say how many were.
- How many in the pipeline? -

The World Health Organization (WHO) has identified 48 "candidate vaccines" at the stage of clinical trials in humans by mid-November, but only 11 at the most advanced Phase 3 stage.

Besides the four that announced results this month are several Chinese vaccines from state-run laboratories, made by Sinovac, Sinopharm and CanSino.

The WHO has identified another 164 vaccine projects that are still in the pre-clinical phase of development.
- What kind of vaccines? -

Some methods for making a vaccine are tried-and-tested, while others remain experimental.

Inactivated traditional vaccines use a virus germ that has been killed, while others use a weakened or "attenuated" strain.

These vaccines work when the body treats the deactivated pathogen as if it were a real threat, producing antibodies to kill it without endangering the patient with full infection.

So-called "sub-unit" vaccines contain a fragment of the virus or bacteria they are derived from to produce a similar immune response.

"Viral vector" varieties deliver fragments of viral DNA into cells, often hitching a lift off of other virus molecules.

For example, a measles virus modified with a coronavirus protein -- the apparatus SARS-CoV-2 uses to latch on to human cells -- can be deployed to provide immunity to Covid-19.

Both Pfizer's and Moderna's vaccines are based on cutting-edge technology that uses synthetic versions of molecules called messenger RNA to hack into human cells, and effectively turn them into vaccine-making factories.
- Is there a vaccine against mistrust? -

Whichever vaccine is the first to be distributed, there's a final question that scientists are powerless to answer but that could determine the success of their efforts: in an era of deep mistrust of authority, how many people will refuse to be vaccinated?

According to a study last month in the Royal Society journal Open Science, a significant percentage of people in many countries subscribe to conspiracy theories about the origin of the vaccines, or the virus itself.

In Mexico, for example, more than a fifth of those questioned said they thought the pandemic itself was "part of a plan to impose vaccinations worldwide".

A survey published earlier this month by the World Economic Forum covering 15 countries found that the number of people willing to be vaccinated had dropped since August from 77 to 73 percent.




(c) 2020 Agence France-Presse

Hk Ab 01:38 GMT November 26, 2020
In again

Hk Ab 01:37 GMT November 26, 2020
Resell 75 1812 on limit. See if it can be hit

Kl Fs 01:23 GMT November 26, 2020
Dx to 88 next month
Looks like usd fate is sealed. 92 gone.

Hk Ab 00:40 GMT November 26, 2020
Same b/e stop for the rest 25

Hk Ab 00:39 GMT November 26, 2020
Exited 25 lots 1808

Hk Ab 00:32 GMT November 26, 2020
All gold ducks are gone?

dc CB 00:25 GMT November 26, 2020
this is good one...

'see ya'

dc CB 00:23 GMT November 26, 2020
this is good one...

happy thanks giving 'Murica.

"just a few more weeks, and we are the f^k outa here. Can't say it's been nice, Wouln't want to go areound twice."
FLOTUS (what a horrible moniker)


Actionable trading levels delivered LIVE to YOUR charts

GVI Trading. Potential Price Risk Scale
AA: Major, A: High, B: Medium

Mon 27 May 2019
AAGB/US- Holiday
Tue 28 May 2019
A 14:00 US- Consumer Confidence
C 13:00 US- Case-Shiller
Wed 29 May 2019
A 08:55 DE- Employment
AA 18:00 US- BOC Decision
A 18:30 US- EIA Crude
Thu 30 Mar 2019
AAEZ/CH- Holiday
A 12:30 US- Weekly Jobless
Fri 31 Mar 2019
AA 10:00 EZ- Flash HICP
A 12:30 US- Personal Income, Spending, Deflator
AA 14:00 US- Final Univ of Michigan

Global-View Affiliate Program

We are starting an affiliate program to market some of our products.

Send me an email if you would be interested or if you know someone who would like to be an affiliate. Generous commissions payout for those accepted.

Put the word "affiliate" in the email subject line.

Contact us

Start trading with forex broker Markets Cube


Retail Forex Brokerage Changing!

Are you looking for your first broker or do you need of a new one? There are more critical things to consider than you might have thought.

We were trading long before there were online brokers. Global-View has been directly involved with the industry since its infancy. We've seen everything and are up-to-data with recent regulatory changes.

Our Best Brokers listing section includes:Forex Broker Reviews, Forex Broker Directory, Forex Broker Comparisons and advice on How to Choose a Forex Broker

If would like guidance, advice, or have any concerns at all ASK US. We are here to help you.

SEE Our Best Brokers List

Currency Trading Tools

  • Live rates, currency news, fx charts. 

  • Research reports and currency forecasts.

  • Foreign Exchange database and history.

  • Weekly economic calendar.

Directory of  Forex trading tools

Terms of Use    Disclaimer    Privacy Policy    Contact    Site Map

Forex Forum
Forex Trading Forum
Forex Forum + forex rates
Forex Forum Archives
Forex Forum RSS
Free Registration

Trading Forums
Currency Forum Guide
Forum Directory
Political Forum
Forex Brokers
Compare Forex Brokers
Forex Broker News
Forex Broker Hotline

Forex Trading Tools
Currency Trading Tools
Forex Database
FX Chart Points
Risk/Carry Trade Chart Points
Economic Calendar
Quicklinks to Economic Data
Currency Futures Swaps
Fibonacci Calculator
Currency Futures Calculator

Forex Education
Forex Learning Center
FX Trading Basics Course
Forex Trading Course
Forex Trading Handbook

Forex Analysis
Forex Forecasts
Interest Rate Forecasts
Central Bank Forecasts

FX Charts and Quotes
Live FX Rates
Live Global Market Quotes
Live Forex Charts
US Dollar Index Chart
Global Chart Gallery
Daily Market Tracker
Forex News
Forex Blog
Forex News
Forex Blog Archives
Forex News RSS
Forex Services
The Amazing Trader
Forex Opportunities
Forex Affiliates
Forex CopyTrading
GVI Forex